Establishment of Medical Advisory Board

AI SummaryClose X

Coiled Therapeutics plc has established a Medical Advisory Board with the appointment of Professor Guru Sonpavde and Dr. Alexander Spira to support the clinical development of its lead oncology drug, AO-252. These founding members bring extensive expertise in early-phase drug development and solid tumour oncology, which will guide AO-252's progression through Phase I trials, including dose escalation and expansion cohorts anticipated in the second half of 2026. This strategic move follows encouraging early clinical signals for AO-252, a TACC3 inhibitor targeting hard-to-treat cancers.

Disclaimer*

UK 100

Latest directors dealings